Wyse DG., Waldo AL., DiMarco JP., Domanski MJ., Rosenberg Y., Schron EB., Kellen JC., Greene HL., Mickel MC., Dalquist JE., Corley SD. A comparison of rate control and rhythm control in patients with atrial fibrillation.. „N Engl J Med”. Dec 5;347. 23, s. 1825-33, 2002. DOI: 10.1056/NEJMoa021328. PMID: 12466506.
Nichol G., McAlister F., Pham B., Laupacis A., Shea B., Green M., Tang A., Wells G. Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. „Heart”. 6 (87), s. 535-543, 2002. DOI: 10.1136/heart.87.6.535. PMID: 12010934. PMCID: PMC1767130.
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. „N Engl J Med”. 321 (6), s. 406-412, 1989. DOI: 10.1056/NEJM198908103210629. PMID: 2473403.
The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. „N Engl J Med”. 327 (4), s. 227-233, 1992. DOI: 10.1056/NEJM199207233270403. PMID: 1377359.
KA. Ellenbogen, BS. Stambler, MA. Wood, PT. Sager i inni. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. „J Am Coll Cardiol”. 28 (1), s. 130-136, 1996. DOI: 10.1016/0735-1097(96)00121-0. PMID: 8752805.
BS. Stambler, MA. Wood, KA. Ellenbogen, KT. Perry i inni. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. „Circulation”. 94 (7), s. 1613-1621, 1996. DOI: 10.1161/01.CIR.94.7.1613. PMID: 8840852.
S. Singh, RG. Zoble, L. Yellen, MA. Brodsky i inni. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. „Circulation”. 102 (19), s. 2385-2390, 2000. DOI: 10.1161/01.CIR.102.19.2385. PMID: 11067793.
nih.gov
ncbi.nlm.nih.gov
Wyse DG., Waldo AL., DiMarco JP., Domanski MJ., Rosenberg Y., Schron EB., Kellen JC., Greene HL., Mickel MC., Dalquist JE., Corley SD. A comparison of rate control and rhythm control in patients with atrial fibrillation.. „N Engl J Med”. Dec 5;347. 23, s. 1825-33, 2002. DOI: 10.1056/NEJMoa021328. PMID: 12466506.
Nichol G., McAlister F., Pham B., Laupacis A., Shea B., Green M., Tang A., Wells G. Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. „Heart”. 6 (87), s. 535-543, 2002. DOI: 10.1136/heart.87.6.535. PMID: 12010934. PMCID: PMC1767130.
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. „N Engl J Med”. 321 (6), s. 406-412, 1989. DOI: 10.1056/NEJM198908103210629. PMID: 2473403.
The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. „N Engl J Med”. 327 (4), s. 227-233, 1992. DOI: 10.1056/NEJM199207233270403. PMID: 1377359.
KA. Ellenbogen, BS. Stambler, MA. Wood, PT. Sager i inni. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. „J Am Coll Cardiol”. 28 (1), s. 130-136, 1996. DOI: 10.1016/0735-1097(96)00121-0. PMID: 8752805.
BS. Stambler, MA. Wood, KA. Ellenbogen, KT. Perry i inni. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. „Circulation”. 94 (7), s. 1613-1621, 1996. DOI: 10.1161/01.CIR.94.7.1613. PMID: 8840852.
S. Singh, RG. Zoble, L. Yellen, MA. Brodsky i inni. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. „Circulation”. 102 (19), s. 2385-2390, 2000. DOI: 10.1161/01.CIR.102.19.2385. PMID: 11067793.